Neurostimulation Devices

Neurostimulation Devices

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Neurostimulation Devices Market to Reach $13.2 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Neurostimulation Devices estimated at US$17.3 Billion in the year 2022, is projected to reach a revised size of US$13.2 Billion by 2030, growing at a CAGR of -3.3% over the analysis period 2022-2030. Spinal Cord Stimulation Devices, one of the segments analyzed in the report, is projected to record a -2.6% CAGR and reach US$4.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Deep Brain Stimulation Devices segment is readjusted to a revised -3.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.6 Billion, While China is Forecast to Grow at -0.1% CAGR
The Neurostimulation Devices market in the U.S. is estimated at US$4.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of -0.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -6.7% and -2.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -5.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2030.

Select Competitors (Total 32 Featured) -
  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Neurostimulation Devices – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 2: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 3: World 18-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 5: World Historic Review for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 6: World 18-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 8: World Historic Review for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 9: World 18-Year Perspective for Spinal Cord Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 11: World Historic Review for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 12: World 18-Year Perspective for Gastric Electric Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 14: World Historic Review for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 15: World 18-Year Perspective for Vagus Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 17: World Historic Review for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 18: World 18-Year Perspective for Sacral Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 20: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 21: World 18-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 23: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 24: World 18-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 26: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 27: World 18-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 29: World Historic Review for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 30: World 18-Year Perspective for Urinary & Fecal Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 33: World 18-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Parkinson`s by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 35: World Historic Review for Parkinson`s by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 36: World 18-Year Perspective for Parkinson`s by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 37: World Recent Past, Current & Future Analysis for Alzheimer`s by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 38: World Historic Review for Alzheimer`s by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 39: World 18-Year Perspective for Alzheimer`s by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
TABLE 40: World Neurostimulation Devices Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 41: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 42: USA Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 43: USA 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: USA Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 46: USA 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 49: Canada 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 52: Canada 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
JAPAN
Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 55: Japan 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 58: Japan 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
CHINA
Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 59: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 60: China Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 61: China 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: China Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 64: China 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
EUROPE
Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 67: Europe 18-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 70: Europe 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 73: Europe 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
FRANCE
Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 74: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: France Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 76: France 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 77: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 78: France Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 79: France 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
GERMANY
Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 81: Germany Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 82: Germany 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 83: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 84: Germany Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 85: Germany 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
ITALY
TABLE 86: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 87: Italy Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 88: Italy 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 89: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 90: Italy Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 91: Italy 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
UNITED KINGDOM
Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
TABLE 92: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 93: UK Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 94: UK 18-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2012, 2023 & 2030
TABLE 95: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 96: UK Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
TABLE 97: UK 18-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal Incontinence, Alzheimer`s and Other Applications for the Years 2012, 2023 & 2030
SPAIN
TABLE 98: Spain Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 99: Spain Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings